Morris, Dr Joanna j.morris.3**[ta]**m.ac.uk
Ubiquitin processing in cancer development and treatment University of Birmingham 01/01/2015
Morrison, Dr David Outcome of cancer patients with critical illness admitted to Intensive Care University of Glasgow 01/07/2013
The above is a list of Cancer Research
CRUK/07/014: FOxTROT: Fluoropyrimidine, Oxaliplatin and Targated Receptor pre-Operative Therapy: a controlled trial in high-risk operable colon cancer (supported by the Bobby Moore fund.)
Mueschen, Professor Markus markus.muschen**[ta]**f.edu Harnessing negative pre-B cell selection to overcome drug-resistance in pre-B acute lymphoblastic leukaemia University of Cambridge 01/07/2014
Mukherjee, Dr Somnath somnath.mukherjee**[ta]**ology.ox.ac.uk
CRUK/07/040: SCALOP 2
Murchie, Dr Peter p.murchie**[ta]**n.ac.uk
Does place of residence, distance and travelling times from health services within Northeast Scotland influence the diagnostic pathway and outcomes from eight common cancers: analysis of a linked
Mussai, Dr Francis francis.mussai**[ta]**.nhs.uk
Understanding and targeting the immunosuppressive microenvironment in
Narita, Dr Masashi Cellular senescence and tumour suppressors Cancer Research UK Cambridge Institute 01/10/2011
Nasmyth, Professor Kim kim.nasmyth**[ta]**ch.ox.ac.uk
Establishment of sister chromatid cohesion by cohesin University of Oxford 01/04/2011
Nathan, Dr Paul CRUKE/13/033: SELPAC: A Randomised 3-arm Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxol in Advanced Uveal Melanoma (AZ/NCRN) University of Liverpool 01/03/2015
Näthke, Professor Inke inke**[ta]**esci.dundee.ac.uk
The adenomatous polyposis protein in colorectal cancer: from biochemistry to tissue architecture University of Dundee 01/10/2009
Neil, Professor James James.Neil**[ta]**sgow.ac.uk
New approaches to modelling human leukaemia University of Glasgow 01/01/2011
Neoptolemos, Professor John Cancer Research UK Liverpool Cancer Trials Unit University of Liverpool 01/10/2013
CRUK/07/024: ESPAC4: EUROPEAN STUDY GROUP FOR PANCREATIC CANCER (ESPAC) -Trial 4.Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer.University of Liverpool 01/12/2007
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Ng, Professor Tony CRUK & EPSRC Cancer Imaging Centre at KCL & UCL King's College London 01/12/2013
Nicholson, Dr James CRUK/10/038: SIOP CNS GCT II: Prospective Trial for the diagnosis and treatment of children, adolescents and young adults with Intracranial Germ Cell Tumours University of Birmingham 01/04/2012
Nicholson, Dr Steve CRUK/13/005: InPACT - International Penile Advanced Cancer Trial (International Rare Cancers Initiative study - IRCI 004) (supported by Stand Up To Cancer) Institute of Cancer Research 01/06/2015
Integrin trafcking in invasion and metastasis Cancer Research UK Beatson Institute 01/03/2014
Nurse, Professor Paul paul.nurse**[ta]**ck.ac.uk
Cancer Research UK Francis Crick Institute Core Grant The Francis Crick Institute 01/04/2015
Cell Cycle Laboratory The Francis Crick Institute 01/10/2012
Nutting, Professor Christopher chris.nutting**[ta]**.nhs.uk
CRUK/14/014: DARS - a phase III randomised multicentre trial of dysphagia optimized intensity modulated radiotherapy versus standard intensity modulated radiotherapy in head and neck cancer Institute of Cancer Research 01/06/2015
O'Brien, Professor Stephen stephen.o'brien**[ta]**castle.ac.uk
CRUKE/09/003: SPIRIT 2: a phase III, prospective randomised comparison of imatinib 400mg daily versus dasatinib 100mg daily in patients with newlydiagnosed chronic phase chronic myeloid leukaemia Newcastle University 01/04/2009
O'Connor, Dr James james.o'connor**[ta]**chester.ac.uk
MRI measurement of tumour spatial heterogeneity: pharmacological biomarker discovery and assay development University of Manchester 01/01/2013
Odom, Dr Duncan Regulatory Circuitry Laboratory Cancer Research UK Cambridge Institute 01/12/2010
O'Driscoll, Professor Mark m.o-driscoll**[ta]**sex.ac.uk
Understanding the wider biological impacts of impaired ATR-ATM DNA damage response pathway function upon signal transduction, cell cycle checkpoint control and DNA repair University of Sussex 01/07/2013
Oelfke, Professor Uwe uwe.oelfke**[ta]**.ac.uk
Optimisation of management in clinical oncology Institute of Cancer Research 01/10/2009
Advances in Physics for Precision Radiotherapy Institute of Cancer Research 01/01/2015
The above is a list of Cancer Research
The role of the actin-myosin cytoskeleton in tissue homeostasis and cancer.Cancer Research UK Beatson Institute 01/03/2014
O'Neill, Dr Eric eric.oneill**[ta]**ology.ox.ac.uk
Signalling
O'Rorke, Dr Michael m.ororke**[ta]**.ac.uk
Beta adrenergic receptor expression and beta-blocker use: association with breast cancer survival and prognosis Queen's University Belfast 01/02/2014
Ottensmeier, Professor Christian CRUKE/10/019: ICE: A Phase II trial of the addition of Ipilimumab to Carboplatin and Etoposide chemotherapy for the frst line treatment of extensive stage small cell lung
Exploratory & preclinical development & CRUKD/17/
CRUKD/15/
Improving Immunotherapy: Understanding and Predicting Protective Immune Responses in
Palmer, Professor Daniel daniel.palmer**[ta]**erpool.ac.uk
CRUK/14/012: CALGB80802 - Phase III randomised study of Sorafenib plus Doxorubicin versus Sorafenib in patients with Advanced Hepatocelluar Carcinoma (HCC) University of Liverpool 01/06/2015
Palmieri, Professor Carlo c.palmieri**[ta]**erpool.ac.uk
CRUK/11/025: IRIS: A Phase II study to assess the safety and efcacy of the steroid sulfatase inhibitor Irosustat in combination with aromatase inhibition in ER positive locally advanced or metastatic breast cancer patients.Imperial College London 01/05/2012
Paraskeva, Professor Chris c.paraskeva**[ta]**stol.ac.uk
Colorectal tumour cell survival mechanisms and
Parker, Dr Chris CRUK/07/008: RADICALS: Randomised phase III trial of adjuvant vs selective salvage treatment after radical prostatectomy for localised prostate cancer University College London 01/04/2007
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Parker, Professor Peter The transformation-associated actions, the signalling network lessons and the intervention opportunities for the PKC superfamily.The Francis Crick Institute 01/11/2012
Partridge, Dr Mike Radiotherapy Physics Reseach Group Cancer Research
Patel, Dr Ketan Genetic insight into ethanol and reactive aldehyde induced DNA damage and epithelial cancer development Medical Research Council Centre - Cambridge 01/06/2012
Paul, Mr James James.Paul**[ta]**sgow.ac.uk
transSCOT - sample collection for translational studies in colorectal cancer University of Glasgow 01/01/2012
Payne, Dr Geoffrey gsp**[ta]**.ac.uk
Evaluation of Lactate as a Biomarker in Clinical Trials of new mechanism-based anti-cancer drugs using 1H Magnetic Resonance Spectroscopy Institute of Cancer Research 01/11/2011
Pearce, Dr Mark mark.pearce**[ta]**.ac.uk
Long-term cancer risks in relation to radiation exposures received due to CT scanning in children and young adults - an extension to the existing
Pearl, Professor Laurence laurence.pearl**[ta]**sex.ac.uk
Structural Biology of DNA Damage Response and Repair Mechanisms and its Exploitation for
Perkins, Professor Neil neil.perkins**[ta]**.ac.uk
New roles for the RelA(p65) NF-kB subunit in cancer Newcastle University 01/06/2011
Petersen, Dr Janni TOR signalling and control of mitotic commitment University of Manchester 01/12/2009
Peto, Professor Sir Richard Clinical Trial Service Unit & Epidemiological Studies Unit University of Oxford 01/04/2014
Pettitt, Professor Andrew a.r.pettitt**[ta]**erpool.ac.uk
CRUKE/09/035: Randomised phase II trial of alemtuzumab, dexamethasone and lenalidomide induction followed by lenalidomide maintenance versus no further treatment for high-risk CLL.University of Liverpool 01/01/2010
CRUKE/10/052: RIAltO: A Randomised Investigation of Alternative Ofatumumab-based regimens for less ft patients with CLL University of Liverpool 01/08/2011
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.CRUK/08/024: PACIFICO (previously RiCh FLO): Purine-Alkylator Combination In Follicular lymphoma Immuno-Chemotherapy for Older patients University of Liverpool 01/11/2008
Serial measurement of the subclinical leukaemic burden as an early biomarker for overt relapse in chronic lymphocytic leukaemia University of Liverpool 01/03/2014
Pharoah, Professor Paul pp10001**[ta]**schl.cam.ac.uk
The genetic and molecular epidemiology of breast and ovarian cancer University of Cambridge 01/10/2013
Phillips, Professor David david.h.phillips**[ta]**.ac.uk
Human biomonitoring and carcinogen activation King's College London 01/10/2012
Picton, Dr Susan susan.picton**[ta]**.net CRUK/13/011: Phase I-II study of Vinblastine in combination with Nilotinib in children, adolescents and young adults with refractory or recurrent low grade glioma: An ITCC and SIOPE-Brain tumour protocol (jointly funded by The Brain Tumour Charity and supported by Stand Up To Cancer) University of Birmingham 01/11/2014
Piddini, Dr Eugenia e.piddini**[ta]**don.cam.ac.uk
Competitive cell interactions in normal physiology and cancer University of Cambridge 01/02/2011
Pillay, Dr Nischalan nischalan.pillay.09**[ta]**.ac.uk
Using genomics to identify new therapeutic avenues for patients with unclassifable
Pines, Professor Jonathon How is mitosis controlled by ubiquitin-mediated proteolysis?
Plummer, Professor Elizabeth Ruth.Plummer**[ta]**castle.ac.uk
CRUKD/08/
CRUKD/12/004: A phase I pharmacokinetic and pharmacodynamic frst in class study of AZD3965, a potent Monocarboxylate Transporter 1 inhibitor (MCT1) in advanced cancer including prostate cancer & NHL expressing MCT1.Newcastle University 01/09/2010
Pollard, Dr Steven steven.pollard**[ta]**ac.uk
The role of SOX and FOX genes in orchestrating transcriptional and epigenetic programs in glioblastoma University of Edinburgh 01/07/2014
The role of SOX and FOX genes in orchestrating transcriptional and epigenetic programs in glioblastoma University of Edinburgh 01/07/2014
The above is a list of Cancer Research
Gene expression patterns as a readout of polygenic susceptibility; potential applications to risk estimation and to prevention in lung cancer University of Cambridge 01/04/2013
Popat, Dr Sanjay sanjay.popat**[ta]**.nhs.uk
CRUKE/10/040: TIMELY: Trial of BIBW
Powell, Dr Melanie melanie.powell**[ta]**tshealth.nhs.uk
CRUK/10/002: DEPICT - Dose Escalation Pelvic IMRT in Cervical Tumours (A Phase I/II dose escalation study of simultaneous integrated boost intensity-modulated radiotherapy for locally advanced cervical cancer) Barts and The London NHS Trust 01/04/2010
CRUK/08/001: PORTEC-3: Randomised Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma.University College London 01/01/2008
- 項目對接快訊
-
- 最新信息
- 熱門信息
